Diabetes Obesity and Metabolism,
Journal Year:
2023,
Volume and Issue:
25(11), P. 3307 - 3316
Published: Aug. 7, 2023
To
examine
disparities
in
glucose-lowering
drug
(GLD)
usage
between
migrants
and
native
Danes
with
type
2
diabetes
(T2D).In
a
nationwide,
register-based
cross-sectional
study
of
253
364
individuals
prevalent
T2D
on
December
31,
2018,
we
examined
user
prevalence
during
2019
(i)
GLD
combination
therapies
(ii)
individual
types.
Migrants
were
grouped
by
origin
(Middle
East,
Europe,
Turkey,
Former
Yugoslavia,
Pakistan,
Sri
Lanka,
Somalia,
Vietnam),
relative
risk
(RR)
versus
was
computed
using
robust
Poisson
regression
to
adjust
for
clinical
socioeconomic
characteristics.In
2019,
34.7%
received
therapy,
lower
most
migrant
groups
(RR
from
0.78,
95%
confidence
interval
CI
0.71-0.85
[Somalia
group]
1.00,
0.97-1.04
[former
Yugoslavia
group]).
Among
Danes,
the
widely
used
oral
metformin
(used
62.1%),
followed
dipeptidyl
peptidase-4
inhibitors
(13.3%),
sodium-glucose
cotransporter-2
(11.9%)
sulphonylureas
(5.2%),
higher
use
any
GLD:
0.99,
0.97-1.01
[Europe
1.09,
1.06-1.11
[Sri
Lanka
Furthermore,
18.7%
insulins
13.3%
glucagon-like
peptide-1
receptor
agonists
(GLP-1RAs),
but
less
insulins:
0.66,
0.62-0.71
0.94,
0.89-0.99
group];
RR
GLP-1RAs:
0.29,
0.22-0.39
0.95,
0.89-1.01
group]).Disparities
types
therapy
evident
Danes.
more
likely
GLDs
injection-based
GLDs,
particularly
GLP-1RAs,
which
may
contribute
complication
mortality
among
this
group.
The Lancet Regional Health - Europe,
Journal Year:
2024,
Volume and Issue:
41, P. 100909 - 100909
Published: April 26, 2024
BackgroundDespite
advances
in
primary
and
secondary
prevention
of
cardiovascular
disease,
excess
mortality
persists
within
the
diabetes
population.
This
study
explores
components
this
their
interaction
with
sex.MethodsUsing
Danish
registries
(2002–2019),
we
identified
residents
aged
18–99
years,
status,
recorded
causes
death.
Applying
Lexis-based
methods,
computed
age-standardized
rates
(asMRs),
relative
risks
(asMRRs),
log-linear
trends
for
cause-specific
mortality.FindingsFrom
2002
to
2019,
958,278
individuals
died
Denmark
(T2D:
148,620;
T1D:
7830)
during
84.4
M
person-years.
During
period,
overall
asMRs
declined,
driven
by
reducing
mortality,
notably
men
T2D.
Conversely,
cancer
remained
high,
making
leading
cause
death
Individuals
T2D
faced
an
elevated
risk
from
nearly
all
types,
ranging
9%
257%
compared
non-diabetic
counterparts.
Notably,
obesity-related
cancers
exhibited
highest
risks:
liver
(Men:
asMRR
3.58
(3.28;
3.91);
Women:
2.49
(2.14;
2.89)),
pancreatic
3.50
(3.25;
3.77);
3.57
(3.31;
3.85)),
kidney
2.10
(1.84;
2.40);
2.31
(1.92;
2.79)).
In
type
2
diabetes,
stable,
except
dementia.
women,
diabetes-related
increased
6–17%
per
decade
across
death,
disease.InterpretationIn
last
decade,
has
emerged
as
among
Denmark,
emphasizing
need
management
strategies
incorporating
prevention.
A
sex-specific
approach
is
crucial
address
persistently
higher
women
diabetes.FundingSupported
Steno
Diabetes
Center
Aarhus,
which
partially
funded
unrestricted
donation
Novo
Nordisk
Foundation,
The
Academy.
Nephrology Dialysis Transplantation,
Journal Year:
2024,
Volume and Issue:
39(7), P. 1150 - 1158
Published: Jan. 2, 2024
ABSTRACT
Background
Chronic
kidney
disease
(CKD)
is
a
growing
global
health
concern.
Identifying
individuals
in
routine
clinical
care
with
new-onset
CKD
at
high
risk
of
rapid
progression
the
imperative
to
guide
allocation
prophylactic
interventions,
but
community-based
data
are
limited.
We
aimed
examine
progression,
failure,
hospitalization
and
death
among
adults
incident
stage
G3
clarify
association
between
predefined
markers
progression.
Methods
Using
plasma
creatinine
measurements
for
entire
Danish
population
from
both
hospitals
primary
care,
we
conducted
nationwide,
population-based
cohort
study,
including
Denmark
2017–2020.
estimated
3-year
risks
(defined
by
confirmed
decline
glomerular
filtration
rate
≥5
mL/min/1.73
m2/year),
all-cause
death.
To
markers,
constructed
heat
map
showing
based
on
markers:
albuminuria,
sex,
diabetes
hypertension/cardiovascular
disease.
Results
Among
133
443
G3,
was
14.6%
[95%
confidence
interval
(CI)
14.4–14.8].
The
were
0.3%
(95%
CI
0.3–0.4),
53.3%
53.0–53.6)
18.1%
17.9–18.4),
respectively.
In
map,
ranged
7%
females
without
or
diabetes,
46%–47%
males
severe
Conclusion
This
study
shows
that
associated
considerable
morbidity
setting
underscores
need
optimized
interventions
such
patients.
Moreover,
our
highlight
potential
using
easily
accessible
identify
who
Primary care diabetes,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Our
aims
were
to
describe
health
care
utilisation
patterns
across
sectors
in
patients
with
type
2
diabetes(T2D),
and
identify
patient
characteristics
associated
low
continuity
of
care.
A
nationwide
register-based
cohort
study
including
all
Danish
citizens
recorded
a
diagnosis
T2
diabetes
2017.
The
outcome
was
as
measured
by
three
different
indices:
the
Continuity
Care
Index
(COCI),
Usual
Provider
(UPC),
Sequential
(SECON).
median
T2D
had
75
%
their
contacts
usual
provider.
strongest
association
number
comorbidities,
showing
dose
response
trend.
Other
duration
(>10.3
years),
lower
age
group
(40-49
having
high
education
level
(>15
years)
cancer
comorbidity.
first
step
flag
at
potential
risk
fragmented
due
many
transitions
between
providers.
This
is
importance
for
general
practitioners,
who
are
coordinators
various
conditions
contacts.
Diabetes Care,
Journal Year:
2024,
Volume and Issue:
47(12), P. 2120 - 2127
Published: May 6, 2024
OBJECTIVE
Type
2
diabetes
often
coexists
with
other
conditions
that
are
amenable
to
pharmacological
treatment.
We
hypothesized
polypharmacy
among
individuals
type
has
increased
since
2000.
RESEARCH
DESIGN
AND
METHODS
Using
Danish
national
registries,
we
established
a
cohort
of
all
(aged
≥18
years)
between
2000
and
2020.
analyzed
their
medication
use
prevalence
varying
degrees
(≥5
or
≥10
medications),
stratifying
by
age,
sex,
number
chronic
diseases,
socioeconomic
status.
RESULTS
The
grew
from
84,917
patients
in
307,011
2020,
totaling
461,849
unique
patients.
daily
medications
used
per
patient
(mean
±
SD)
3.7
2.8
(in
2000)
5.3
3.2
2020).
lifetime
risk
was
substantial,
89%
(n
=
409,062
461,849)
being
exposed
≥5
at
some
point
47%
217,467
medications.
increases
were
driven
an
expanding
group
medications,
analgesics,
antihypertensives,
proton
pump
inhibitors,
statins
having
the
largest
net
increase.
Advanced
male
lower
status,
ethnicity
positively
correlated
but
could
not
explain
overall
increase
polypharmacy.
CONCLUSIONS
Medication
have
diabetes.
Although
implications
appropriateness
this
uncertain,
results
stress
increasing
need
for
health
care
personnel
understand
potential
risks
associated
polypharmacy,
including
interactions,
adverse
effects,
over-
underprescribing.
Journal of Dental Research,
Journal Year:
2024,
Volume and Issue:
103(9), P. 870 - 877
Published: Aug. 1, 2024
Conflicting
evidence
suggests
a
link
between
diabetes-related
microvascular
complications
and
periodontitis.
Reliable
estimates
have
been
hindered
by
small
sample
sizes
residual
confounding.
Moreover,
the
combined
effects
of
dyslipidemia
on
periodontitis
not
explored.
Therefore,
this
study
aimed
to
investigate
association
individual
diabetic
(i.e.,
neuropathy
retinopathy)
moderate/severe
in
Danish
population-based
study.
In
addition,
we
assessed
whether
modified
these
associations.
This
comprised
15,922
participants
with
type
2
diabetes
from
Health
Central
Denmark
Multinomial
logistic
regression
was
used
estimate
odds
ratios
(ORs)
95%
confidence
intervals
(CIs)
for
joint
complications.
The
models
adjusted
potential
confounders,
including
sociodemographic
factors,
lifestyle
behaviors,
health
conditions.
Inverse
probability
treatment
weighting
(IPTW)
balanced
measured
confounders
nonperiodontitis
participants.
Sensitivity
analyses
tested
findings'
robustness
estimating
E-values
unmeasured
confounding
varying
complication
definitions.
After
IPTW,
revealed
that
(OR
1.36,
CI
1.14
1.63)
retinopathy
1.21,
1.03
1.43)
were
significantly
associated
coexistence
increased
1.5-fold
1.51,
1.23
1.85).
An
effect
modification
an
additive
scale
found,
indicated
positive
relative
excess
risk
due
interaction
0.24
neuropathy,
0.11
retinopathy,
0.44
both
analysis
ruled
out
definitions
as
explanatory
factors.
Diabetic
individually
combined,
had
complications,
elevating
These
findings
may
aid
identifying
at-risk
subgroups
periodontitis,
optimizing
efforts
mitigate
disease
burden.
Diabetes Research and Clinical Practice,
Journal Year:
2023,
Volume and Issue:
203, P. 110829 - 110829
Published: July 13, 2023
To
estimate
the
prevalence,
incidence,
mortality,
and
risk
of
progression
to
type
2
diabetes
for
individuals
with
HbA1c-defined
prediabetes
based
on
Danish
nationwide
population-based
laboratory
databases.We
included
all
HbA1c
measurements
from
general
practice
hospitals
during
2012
2018.
We
estimated
cumulative
incidence
having
at
least
one
measurement.
The
prevalence
rates
(HbA1c
42-47
mmol/mol)
were
examined
in
adult
population.
5-year
was
death
as
competing
event.Among
4,979,590
Danes,
70.8%
(95%
CI
70.8-70.9)
had
measurement
7.1%
7.1-7.1)
rate
14.2
14.1-14.3)
per
1,000
person-years,
median
age
66.9
years
(IQR
56.7-75.7)
43
mmol/mol
42-44)
diagnosis.
Within
five
years,
17.5%
17.3-17.7)
died
21.3%
21.1-21.5).Out
100
adults,
1.4
develop
each
year
they
can
be
identified
an
early
stage
databases.
progresses
six
dies.
TH Open,
Journal Year:
2024,
Volume and Issue:
08(01), P. e146 - e154
Published: Jan. 1, 2024
Abstract
Background
Bleeding
and
venous
thromboembolism
(VTE)
are
adverse
outcomes
after
colorectal
cancer
(CRC)
surgery.
Type
2
diabetes
(T2D)
clusters
with
bleeding
VTE
risk
factors.
We
examined
the
in
patients
T2D
undergoing
CRC
surgery
prognosis
these
outcomes.
Methods
conducted
a
prognostic
population-based
cohort
study
of
48,295
without
for
incident
during
2005
to
2019.
Patients
were
diagnosed
hospital
setting
or
had
redeemed
glucose-lowering
drug
prescription;
remaining
was
diabetes.
estimated
30-day
1-year
risks
used
Fine–Gray
model
compute
age-,
sex-,
calendar
year-adjusted
subdistribution
hazard
ratios
(SHRs).
The
Kaplan–Meier
method
calculate
mortality
VTE.
Results
Within
30
days
surgery,
2.7%
2.0%
(SHR:
1.30
[95%
confidence
interval
[CI]:
1.10–1.53]).
For
VTE,
0.6%
1.01
CI:
0.71–1.42]).
SHRs
within
1
year
similar.
26.0%
versus
24.9%
25.8%
27.5%
diabetes,
respectively.
Conclusion
Although
absolute
low,
have
an
increased
but
not
European Journal of Neurology,
Journal Year:
2024,
Volume and Issue:
31(12)
Published: Oct. 6, 2024
Abstract
Background
and
Purpose
Previous
studies
have
reported
conflicting
results
regarding
the
association
between
influenza
vaccination
dementia.
This
was
investigated
in
a
nationwide
register‐based
cohort
study.
Methods
Using
registries,
dementia‐free
adults
aged
≥65
years
Denmark
from
2002
to
2018
without
previous
vaccinations
were
included.
Poisson
regression
facilitated
confounder‐adjusted
comparisons
of
dementia
rates
for
ever
versus
never
vaccinated,
number
within/after
5
first
vaccination.
Sensitivity
analyses
included
stratification
on
age
sex.
Results
Vaccination
during
follow‐up
associated
with
slightly
higher
rate
when
adjusted
sociodemographic
factors
comorbidities,
both
within
after
(incidence
ratio
[IRR]
1.04;
95%
confidence
interval
[CI]
1.03–1.05).
The
decreased
increasing
vaccinations.
highest
amongst
those
only
one
(IRR
1.14;
CI
1.12–1.17)
six
or
more
0.95;
0.93–0.97).
Applying
same
models
control
outcomes
hip
fracture
cancer
resulted
vaccinated
people
6%
7%,
respectively.
Vaccinated
also
had
10%
mortality
rate.
Discussion
Our
do
not
support
case
preventive
effect
risk
general
population,
as
by
some
studies.
However,
found
this
study
is
probably
due
residual
confounding,
indicated
mortality.